← back to search

Anna L. Bruckner

University of Colorado Denver · US
Area of research
Cell Biology · Pathology and Forensic Medicine
Research interest
Research interests include Epidermolysis bullosa, Medicine, Mutation, Dermatology, Epidermolysis bullosa simplex, and Ichthyosis.
h-index
citations
498
works
9
NIH funding
primary concept
email

Recent publications

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation
Journal of Medical Genetics 2025cited by 1position: middledoi
Biologics in congenital ichthyosis: are they effective?
British Journal of Dermatology 2024cited by 18position: middledoi
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
Nature Communications 2024cited by 18position: middledoi
Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest sephardic ancestry
American Journal of Medical Genetics Part A 2021cited by 7position: middledoi
The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers
Orphanet Journal of Rare Diseases 2020cited by 184position: firstdoi
Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents
Pediatric Dermatology 2020cited by 73position: middledoi
Skin cleansing and topical product use in patients with epidermolysis bullosa: Results from a multicenter database
Pediatric Dermatology 2020cited by 20position: middledoi
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
Science Translational Medicine 2018cited by 132position: middledoi
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America
JAMA Dermatology 2018cited by 45position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Lawrence F. Eichenfield · University of San Diego3 papers (2018–2020)Moise L. Levy · Dell Children's Medical Center of Central Texas3 papers (2018–2020) · 3 papers (2018–2020)John Browning · Amgen (United States)2 papers (2018–2020)Lawrence A. Schachner · University of Miami2 papers (2018–2020) · 2 papers (2018–2020)Catherine McCuaïg · McGill University2 papers (2018–2020)Elena Pope · University of Toronto2 papers (2018–2020)Kimberly D. Morel · Columbia University2 papers (2018–2020)Kristen P. Hook · University of Minnesota, Twin Cities2 papers (2018–2020)Irene Lara Corrales · Hospital for Sick Children2 papers (2018–2020)Laura E. Levin · Medical College of Wisconsin2 papers (2018–2020)Amy S. Paller · Northwestern University2 papers (2018–2020)Karen Wiss · University of Massachusetts Chan Medical School2 papers (2018–2020)Andrea L. Zaenglein · Pennsylvania State University1 papers (2020–2020)James A. Feinstein · Children's Hospital Colorado1 papers (2018–2018) · 1 papers (2020–2020)Leila H. Shayegan · Brigham and Women's Hospital1 papers (2020–2020) · 1 papers (2020–2020)Marla Jahnke · Henry Ford Health System1 papers (2018–2018)